• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting insulin-like growth factor signaling: rational combination strategies.

作者信息

Olmos David, Basu Bristi, de Bono Johann S

出版信息

Mol Cancer Ther. 2010 Sep;9(9):2447-9. doi: 10.1158/1535-7163.MCT-10-0719. Epub 2010 Aug 31.

DOI:10.1158/1535-7163.MCT-10-0719
PMID:20807783
Abstract
摘要

相似文献

1
Targeting insulin-like growth factor signaling: rational combination strategies.靶向胰岛素样生长因子信号传导：合理的联合策略。
Mol Cancer Ther. 2010 Sep;9(9):2447-9. doi: 10.1158/1535-7163.MCT-10-0719. Epub 2010 Aug 31.
2
Targeting the insulin growth factor receptor 1.靶向胰岛素样生长因子受体 1。
Hematol Oncol Clin North Am. 2012 Jun;26(3):527-42, vii-viii. doi: 10.1016/j.hoc.2012.01.004. Epub 2012 Feb 28.
3
Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth.双 IGF-I/II 中和抗体 MEDI-573 能够强烈抑制 IGF 信号和肿瘤生长。
Cancer Res. 2011 Feb 1;71(3):1029-40. doi: 10.1158/0008-5472.CAN-10-2274. Epub 2011 Jan 18.
4
Human monoclonal antibody fragments binding to insulin-like growth factors I and II with picomolar affinity.与人胰岛素样生长因子 I 和 II 具有皮摩尔亲和力的人源单克隆抗体片段。
Mol Cancer Ther. 2011 Sep;10(9):1677-85. doi: 10.1158/1535-7163.MCT-11-0281. Epub 2011 Jul 12.
5
Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response.两种靶向不同表位的胰岛素样生长因子-I 受体抑制性抗体的联合应用可增强抗肿瘤反应。
Mol Cancer Ther. 2010 Sep;9(9):2593-604. doi: 10.1158/1535-7163.MCT-09-1018. Epub 2010 Aug 17.
6
Minireview: IGF, Insulin, and Cancer.综述：IGF、胰岛素与癌症。
Endocrinology. 2011 Jul;152(7):2546-51. doi: 10.1210/en.2011-0231. Epub 2011 May 3.
7
Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin.全人源胰岛素样生长因子（IGF）配体中和抗体BI 836845的药效学及抗肿瘤活性，以及与雷帕霉素联合使用的作用机制原理
Mol Cancer Ther. 2014 Feb;13(2):399-409. doi: 10.1158/1535-7163.MCT-13-0598. Epub 2013 Dec 2.
8
Targeting the type I insulin-like growth factor system for breast cancer therapy.针对乳腺癌治疗的 I 型胰岛素样生长因子系统。
Curr Drug Targets. 2010 Sep;11(9):1121-32. doi: 10.2174/138945010792006816.
9
Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.循环胰岛素样生长因子可能对胰岛素受体同工型 A 和胰岛素受体同工型 B 的信号传递有重要贡献。
Mol Cell Endocrinol. 2013 Jan 5;365(1):17-24. doi: 10.1016/j.mce.2012.08.021. Epub 2012 Sep 7.
10
The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.胰岛素样生长因子 (IGF) 轴作为前列腺癌的抗癌靶点。
Cancer Lett. 2015 Oct 28;367(2):113-21. doi: 10.1016/j.canlet.2015.07.026. Epub 2015 Jul 29.

引用本文的文献

1
Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.抑制 RPS6K 揭示了腔面乳腺癌细胞中依赖于上下文的 Akt 活性。
PLoS Comput Biol. 2021 Jun 30;17(6):e1009125. doi: 10.1371/journal.pcbi.1009125. eCollection 2021 Jun.
2
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.胰岛素样生长因子-1受体（IGF-1R）与雷帕霉素靶蛋白（mTOR）阻断：尤因肉瘤的新型耐药机制与协同药物组合
J Natl Cancer Inst. 2016 Aug 30;108(12). doi: 10.1093/jnci/djw182. Print 2016 Dec.
3
Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways.
蛋白质组学筛选与套索回归揭示胰岛素和胰岛素样生长因子I（IGF1）信号通路的差异
Mol Cell Proteomics. 2016 Sep;15(9):3045-57. doi: 10.1074/mcp.M115.057729. Epub 2016 Jun 30.
4
Recent developments in receptor tyrosine kinases targeted anticancer therapy.受体酪氨酸激酶靶向抗癌治疗的最新进展。
Vet World. 2016 Jan;9(1):80-90. doi: 10.14202/vetworld.2016.80-90. Epub 2016 Jan 29.
5
Succinate dehydrogenase-deficient gastrointestinal stromal tumors.琥珀酸脱氢酶缺乏型胃肠道间质瘤
World J Gastroenterol. 2015 Feb 28;21(8):2303-14. doi: 10.3748/wjg.v21.i8.2303.
6
Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma.IGFBP2 的下调与横纹肌肉瘤对 IGF1R 治疗的耐药性有关。
Oncogene. 2014 Dec 11;33(50):5697-705. doi: 10.1038/onc.2013.509. Epub 2013 Dec 2.
7
The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.TP53突变与结直肠癌对胰岛素样生长因子-1受体抑制剂鬼臼苦素耐药性的关联。
BMC Cancer. 2013 Nov 4;13:521. doi: 10.1186/1471-2407-13-521.
8
Impact of targeting insulin-like growth factor signaling in head and neck cancers.靶向胰岛素样生长因子信号传导对头颈部癌症的影响。
Growth Horm IGF Res. 2013 Oct;23(5):135-40. doi: 10.1016/j.ghir.2013.06.001. Epub 2013 Jun 29.
9
Dependence of Wilms tumor cells on signaling through insulin-like growth factor 1 in an orthotopic xenograft model targetable by specific receptor inhibition.胰岛素样生长因子 1 信号通路在 Wilms 瘤细胞中的依赖性及其在同种异体移植模型中的靶向性研究
Proc Natl Acad Sci U S A. 2012 May 15;109(20):E1267-76. doi: 10.1073/pnas.1105034109. Epub 2012 Apr 23.
10
Clinical development of insulin-like growth factor receptor--1 (IGF-1R) inhibitors: at the crossroad?胰岛素样生长因子受体-1（IGF-1R）抑制剂的临床研发：在十字路口？
Invest New Drugs. 2012 Dec;30(6):2433-42. doi: 10.1007/s10637-012-9811-0. Epub 2012 Mar 14.